April 2024
1. LEI CL, Whittaker DG, Mirams GR
   The impact of uncertainty in hERG binding mechanism on in silico predictions of drug-induced proarrhythmic risk.
   Br J Pharmacol. 2024;181:987-1004.
   

   >> Share

   
   February 2024
2. CHEN IS, Yasuda J, Notomi T, Nakamura TY, et al
   Licorice metabolite 18beta-glycyrrhetinic acid activates G protein-gated inwardly rectifying K(+) channels.
   Br J Pharmacol. 2024;181:447-463.
   

   >> Share

   
   December 2022
3. SAADEH K, Nantha Kumar N, Fazmin IT, Edling CE, et al
   Anti-malarial drugs: Mechanisms underlying their proarrhythmic effects.
   Br J Pharmacol. 2022;179:5237-5258.
   

   >> Share

   
   October 2022
4. CLARK AP, Wei S, Kalola D, Krogh-Madsen T, et al
   An in silico-in vitro pipeline for drug cardiotoxicity screening identifies ionic pro-arrhythmia mechanisms.
   Br J Pharmacol. 2022;179:4829-4843.
   

   >> Share

   
   July 2022
5. KOHAJDA Z, Virag L, Hornyik T, Husti Z, et al
   In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
   Br J Pharmacol. 2022;179:3382-3402.
   

   >> Share

   
   June 2022
6. CHAMPEROUX P, Fares R, Bastogne T, Richard S, et al
   Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
   Br J Pharmacol. 2022 Jun 24. doi: 10.1111/bph.15905.
   

   >> Share

   
   
7. BANNISTER ML, MacLeod KT, George CH
   Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.
   Br J Pharmacol. 2022;179:2558-2563.
   

   >> Share

   
   May 2022
8. HESKETH LM, Sikkel MB, Mahoney-Sanchez L, Mazzacuva F, et al
   OCT2013, an ischaemia-activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine.
   Br J Pharmacol. 2022;179:2037-2053.
   

   >> Share

   
   March 2022
9. HORNYIK T, Rieder M, Castiglione A, Major P, et al
   Transgenic rabbit models for cardiac disease research.
   Br J Pharmacol. 2022;179:938-957.
   

   >> Share

   
   
10. LOEN V, Vos MA, van der Heyden MAG
    The canine chronic atrioventricular block model in cardiovascular preclinical drug research.
    Br J Pharmacol. 2022;179:859-881.
    

    >> Share

    
    December 2021
11. ROBINSON VM, Alsalahat I, Freeman S, Antzelevitch C, et al
    A Carvedilol Analogue, VK-II-86, Prevents Hypokalaemia-induced Ventricular Arrhythmia through Novel multi-Channel Effects.
    Br J Pharmacol. 2021 Dec 7. doi: 10.1111/bph.15775.
    

    >> Share

    
    November 2021
12. SANDER P, Feng M, Schweitzer MK, Wilting F, et al
    Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca(2+) uptake and suppress cardiac arrhythmogenesis.
    Br J Pharmacol. 2021;178:4518-4532.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share